Stannous Fluoride
CAS 7783-47-3
Stannous Fluoride (CAS 7783-47-3) is a pharmaceutical compound with 0 bioactivity targets and 28 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Adverse Event Associations
DrugCentral / FAERS disproportionality signal rows matched to this compound.
| Reaction PT | Drug AE | LLR | MedDRA |
|---|---|---|---|
| Respiratory tract infection bacterial | 25 | 137.767 | 10060693 |
| Cytokine release syndrome | 39 | 122.759 | 10052015 |
| Respiratory tract infection viral | 26 | 122.716 | 10062106 |
| Fibrin D dimer increased | 22 | 86.521 | 10016581 |
| Respiratory tract infection | 27 | 62.092 | 10062352 |
| Platelet count decreased | 33 | 41.305 | 10035528 |
| Pulmonary embolism | 30 | 38.416 | 10037377 |
| Haemoglobin decreased | 29 | 30.115 | 10018884 |
| C-reactive protein increased | 23 | 29.795 | 10006825 |
| Hypotension | 39 | 29.719 | 10021097 |
| Thrombocytopenia | 30 | 26.762 | 10043554 |
| Pyrexia | 47 | 25.175 | 10037660 |
| COVID-19 | 23 | 24.79 | 10084268 |
Association rows are source-linked signal records, not incidence rates or clinical causality claims.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| STANNOUS FLUORIDE | 10030 | SU | MTHSPL |
| Stannous Fluoride | 10030 | SU | MTHSPL |
| stannous fluoride | 10030 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Stannous Fluoride used for in pharmaceutical contexts?
Stannous Fluoride (CAS 7783-47-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Stannous Fluoride?
Stannous Fluoride has 28 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Respiratory tract infection bacterial, Cytokine release syndrome, Respiratory tract infection viral, Fibrin D dimer increased, Respiratory tract infection. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Stannous Fluoride also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Stannous Fluoride with EU status "restricted".
What clinical phase is Stannous Fluoride in?
No phase 1-4 clinical development badge is rendered for Stannous Fluoride because the matched compound identifier rows do not contain a max-phase value.